Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

2030 ARTíCULOS , VIENDO DEL 1 AL 15

PUBMED

Rehabilitation in Parkinson's disease: assessing the outcome using objective metabolic measurements.

Frazzitta G, Maestri R, Bertotti G, Uccellini D, Bazzini G, Abelli P, Aquilani R.

Mov Disord. 2010 Apr 15;25(5):609-14. doi: 10.1002/mds.22871.

0

0

0

PUBMED

Major life events and risk of Parkinson's disease.

Rod NH, Hansen J, Schernhammer E, Ritz B.

Mov Disord. 2010 Aug 15;25(11):1639-45. doi: 10.1002/mds.22850.

0

0

0

PUBMED

Reprogramming guided by the fused images of MRI and CT in subthalamic nucleus stimulation in Parkinson disease.

Lee JY, Jeon BS, Paek SH, Lim YH, Kim MR, Kim C.

Clin Neurol Neurosurg. 2010 Jan;112(1):47-53. doi: 10.1016/j.clineuro.2009.10.008.

0

0

0

PUBMED

Vesicular monoamine transporter 2 mRNA levels are reduced in platelets from patients with Parkinson's disease.

Sala G, Brighina L, Saracchi E, Fermi S, Riva C, Carrozza V, Pirovano M, Ferrarese C.

J Neural Transm (Vienna). 2010 Sep;117(9):1093-8. doi: 10.1007/s00702-010-0446-z.

0

0

0

PUBMED

Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease.

Tang CC, Poston KL, Dhawan V, Eidelberg D.

J Neurosci. 2010 Jan 20;30(3):1049-56. doi: 10.1523/JNEUROSCI.4188-09.2010.

0

0

0

PUBMED

The effect of levodopa treatment on cerebral hemodynamics in patients with Parkinson's disease: serial transcranial Doppler studies.

Yong SW, Lee KY, Lee PH.

Parkinsonism Relat Disord. 2010 Mar;16(3):225-7. doi: 10.1016/j.parkreldis.2009.09.003.

0

0

0

PUBMED

Hyperhomocysteinemia due to levodopa treatment as a risk factor for osteoporosis in patients with Parkinson's disease.

Lee SH, Kim MJ, Kim BJ, Kim SR, Chun S, Kim HK, Ryu JS, Kim GS, Lee MC, Chung SJ, Koh JM.

Calcif Tissue Int. 2010 Feb;86(2):132-41. doi: 10.1007/s00223-009-9327-6.

0

0

0

PUBMED

The effect of Parkinson's disease on the dynamics of on-line and proactive cognitive control during action selection.

Wylie SA, Ridderinkhof KR, Bashore TR, van den Wildenberg WP.

J Cogn Neurosci. 2010 Sep;22(9):2058-73. doi: 10.1162/jocn.2009.21326.

0

0

0

PUBMED

Lower extremity isokinetic muscle strength in patients with Parkinson's disease.

Durmus B, Baysal O, Altinayar S, Altay Z, Ersoy Y, Ozcan C.

J Clin Neurosci. 2010 Jul;17(7):893-6. doi: 10.1016/j.jocn.2009.11.014.

0

0

0

PUBMED

Analysis of exon dosage using MLPA in South African Parkinson's disease patients.

Keyser RJ, Lombard D, Veikondis R, Carr J, Bardien S.

Neurogenetics. 2010 Jul;11(3):305-12. doi: 10.1007/s10048-009-0229-6.

0

0

0

PUBMED

Continuous subcutaneous infusion of apomorphine can be used safely in patients with Parkinson's disease and pre-existing visual hallucinations.

van Laar T, Postma AG, Drent M.

Parkinsonism Relat Disord. 2010 Jan;16(1):71-2. doi: 10.1016/j.parkreldis.2009.05.006. No abstract available.

0

0

0

PUBMED

The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia.

Schulz-Schaeffer WJ.

Acta Neuropathol. 2010 Aug;120(2):131-43. doi: 10.1007/s00401-010-0711-0. Review.

0

0

0

PUBMED

Transdermal rotigotine for the perioperative management of Parkinson's disease.

Wüllner U, Kassubek J, Odin P, Schwarz M, Naumann M, Häck HJ, Boroojerdi B, Reichmann H; NEUPOS Study Group..

J Neural Transm (Vienna). 2010 Jul;117(7):855-9. doi: 10.1007/s00702-010-0425-4.

0

0

0

PUBMED

Preventing Parkinson's pathology.

DeSantis ME, Dersh D.

Dis Model Mech. 2010 Jul-Aug;3(7-8):399-400. doi: 10.1242/dmm.005678. No abstract available.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy